Flow cytometric analysis of human CD6 expression on human PBMCs (human peripheral blood mononuclear cells). Human PBMCs were stained with Brilliant Violet 421™ Mouse Anti-Human CD3 Antibody and either Biotin Mouse IgG1, k Isotype Control (left panel) or SDT Biotin Mouse Anti-Human CD6 Antibody (right panel) at 5 μl/test followed by Sav-iFluor 488. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
Product Details
Product Details
Product Specification
| Host | Mouse |
| Antigen | CD6 |
| Synonyms | T-cell differentiation antigen CD6; T12; TP120 |
| Location | Cell membrane |
| Accession | P30203 |
| Clone Number | S-3174 |
| Antibody Type | Mouse mAb |
| Isotype | IgG1,k |
| Isotype Control | S0B5431 |
| Application | FCM |
| Reactivity | Hu |
| Positive Sample | human PBMC |
| Purification | Protein G |
| Concentration | 0.2 mg/ml |
| Conjugation | Biotin |
| Physical Appearance | Liquid |
| Storage Buffer | PBS pH7.4, 0.09% sodium azide |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| FCM | 5μl per million cells in 100μl volume | Hu |
Background
CD6 is a type I transmembrane glycoprotein primarily expressed on the surface of T cells and a subset of B cells, belonging to the scavenger receptor superfamily. Its structure comprises three scavenger receptor cysteine-rich (SRCR) domains, a proline-rich spacer region, and a cytoplasmic tail containing multiple conserved signaling motifs. By interacting with its ligand CD166 (ALCAM), which is expressed on antigen-presenting cells, CD6 directly participates in the regulation of T cell activation, proliferation, migration, and differentiation. As a co-stimulatory molecule in the T cell receptor signaling pathway, CD6 not only enhances T cell sensitivity to antigens but also influences immune tolerance by modulating thymocyte selection. In recent years, CD6 has emerged as a therapeutic target for autoimmune diseases such as multiple sclerosis, where monoclonal antibodies targeting the CD6-CD166 pathway can inhibit excessive immune responses, highlighting its critical role in immune regulation.
Picture
Picture
FC
